Novartis India Ltd.
|Rabeprazole Sodium||20 mg|
Click on the API name to know their properties
|Composit uses/ indication of Rabonik DSR :|
Acute nausea and vomiting, Dyspepsia, Functional dyspepsia, Gastric distension pain due to pressure on the stomach, Gastro-oesophageal reflux disease, Nausea and vomiting, Nausea and vomiting (chemotherapy induced), Nausea and vomiting (L-dopa induced), Non-ulcer dyspepsia, Reflux oesophagitis.
A proton pump inhibitor, prescribed for duodenal ulcer, gastro esophageal reflux disease (GERD), and Zollinger-Ellison (gastric acid hyper secretion) syndrome. It works by decreasing the amount of acid made in the stomach.
|Composit contra indication of Rabonik DSR :|
Allergy, Serious resistant GI mycoses, Hepatic impairment.
|Composit side effects of Rabonik DSR :|
Anaphylactic shock, angioedema, allergic reaction, increased prolactin levels, agitation, nervousness, extrapyramidal side effects, convulsions, somnolence, headache, gastro-intestinal disorders, transient intestinal Cramps, hives, itch, rash, galactorrhoea, excessive development of the breasts in males, amenorrhoea, ventricular arrhythmias, QTc prolongation, liver function test abnormal.
Headache, Diarrhea, Nervousness, Abdominal pain, Pharyngitis, Weight gain, Cough, Asthenia, Influenza like syndrome, Rhinitis, Chest pain, UTI, Sinusitis.
|Composit caution of Rabonik DSR :|
Phaeochromocytoma, children below 2 yr, elderly, renal or hepatic impairment. Risk of cardiac arrhythmias and hypokalaemia if administered IV. Pregnancy and lactation.
Severe hepatic impairment, gastric malignancy. May increase the risk of GI infections due to acid suppressive effects. Pregnancy.
Cadila Pharmaceuticals Limited